Mason MD - Search Results

1

Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array.

Welton JL, Brennan P, Gurney M, Webber JP, Spary LK, Carton DG, Falcón-Pérez JM, Walton SP, Mason MD, Tabi Z, Clayton A. Welton JL, et al. Among authors: mason md. J Extracell Vesicles. 2016 Jun 29;5:31209. doi: 10.3402/jev.v5.31209. eCollection 2016. J Extracell Vesicles. 2016. PMID: 27363484 Free PMC article.

2

Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry.

Clayton A, Court J, Navabi H, Adams M, Mason MD, Hobot JA, Newman GR, Jasani B. Clayton A, et al. Among authors: mason md. J Immunol Methods. 2001 Jan 1;247(1-2):163-74. doi: 10.1016/s0022-1759(00)00321-5. J Immunol Methods. 2001. PMID: 11150547

3

Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.

Clayton A, Harris CL, Court J, Mason MD, Morgan BP. Clayton A, et al. Among authors: mason md. Eur J Immunol. 2003 Feb;33(2):522-31. doi: 10.1002/immu.200310028. Eur J Immunol. 2003. PMID: 12645951 Free article.

4

Adhesion and signaling by B cell-derived exosomes: the role of integrins.

Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB. Clayton A, et al. Among authors: mason md. FASEB J. 2004 Jun;18(9):977-9. doi: 10.1096/fj.03-1094fje. Epub 2004 Apr 1. FASEB J. 2004. PMID: 15059973

5

The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer.

Adams M, Navabi H, Croston D, Coleman S, Tabi Z, Clayton A, Jasani B, Mason MD. Adams M, et al. Among authors: mason md. Vaccine. 2005 Mar 18;23(17-18):2374-8. doi: 10.1016/j.vaccine.2005.01.014. Vaccine. 2005. PMID: 15755631

6

Induction of heat shock proteins in B-cell exosomes.

Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z. Clayton A, et al. Among authors: mason md. J Cell Sci. 2005 Aug 15;118(Pt 16):3631-8. doi: 10.1242/jcs.02494. Epub 2005 Jul 26. J Cell Sci. 2005. PMID: 16046478

7

Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial.

Navabi H, Croston D, Hobot J, Clayton A, Zitvogel L, Jasani B, Bailey-Wood R, Wilson K, Tabi Z, Mason MD, Adams M. Navabi H, et al. Among authors: mason md. Blood Cells Mol Dis. 2005 Sep-Oct;35(2):149-52. doi: 10.1016/j.bcmd.2005.06.008. Blood Cells Mol Dis. 2005. PMID: 16061407

8

Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer.

Coleman S, Clayton A, Mason MD, Jasani B, Adams M, Tabi Z. Coleman S, et al. Among authors: mason md. Cancer Res. 2005 Aug 1;65(15):7000-6. doi: 10.1158/0008-5472.CAN-04-3792. Cancer Res. 2005. PMID: 16061686

9

Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.

Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Clayton A, et al. Among authors: mason md. Cancer Res. 2007 Aug 1;67(15):7458-66. doi: 10.1158/0008-5472.CAN-06-3456. Cancer Res. 2007. PMID: 17671216

10

Increased exosome production from tumour cell cultures using the Integra CELLine Culture System.

Mitchell JP, Court J, Mason MD, Tabi Z, Clayton A. Mitchell JP, et al. Among authors: mason md. J Immunol Methods. 2008 Jun 1;335(1-2):98-105. doi: 10.1016/j.jim.2008.03.001. Epub 2008 Apr 3. J Immunol Methods. 2008. PMID: 18423480

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters